Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3666)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 15, 2023 (publication date) through Jun 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li DD, Tang YL, Wang X. Challenges and exploration for immunotherapies targeting cold colorectal cancer. World J Gastrointest Oncol 2023; 15(1): 55-68 [PMID: 36684057 DOI: 10.4251/wjgo.v15.i1.55] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i1/55.htm |
| Number | Citing Articles |
| 1 |
Takehiko Yokobori. Editorial Comment on: The Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein–Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After Surgery. Annals of Surgical Oncology 2023; 30(11): 6306 doi: 10.1245/s10434-023-13761-4
|
| 2 |
Edward Zheng, Marcin Włodarczyk, Andrzej Węgiel, Aleksandra Osielczak, Maria Możdżan, Laura Biskup, Agata Grochowska, Maria Wołyniak, Dominik Gajewski, Mateusz Porc, Kasper Maryńczak, Łukasz Dziki. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1398289
|
| 3 |
Aitoshi Hoshimoto, Atsushi Tatsuguchi, Ryohei Hamakubo, Takayoshi Nishimoto, Jun Omori, Naohiko Akimoto, Shu Tanaka, Shunji Fujimori, Tsutomu Hatori, Akira Shimizu, Katsuhiko Iwakiri. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. World Journal of Gastroenterology 2023; 29(40): 5566-5581 doi: 10.3748/wjg.v29.i40.5566
Abstract(275) |
Core Tip(315) |
Full Article(HTML)(1215)
|
Full Article with Cover (PDF)-4633K(56)
|
Full Article (Word)-1014K(30)
|
Audio-989K(4)
|
Peer-Review Report-253K(32)
|
Answering Reviewers-96K(30)
|
Supplementary Material-53K(35)
|
Full Article (PDF)-4374K(105)
|
Full Article (XML)-200K(33)
|
Times Cited (2)
|
Total Visits (4425)
|
Open
|
| 4 |
Rui-ting Ma, Yuanyuan Wang, Feng Ji, Jian-nan Chen, Tian-jun Wang, Yan Liu, Ming-xing Hou, Zhi-gang Guo. YTHDF1’s grip on CRC vasculature: insights into LINC01106 and miR-449b-5p-VEGFA axis. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03360-y
|
| 5 |
Brindley Hapuarachi, Sarah Danson, Jon Wadsley, Munitta Muthana. Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1335256
|
| 6 |
Gholam‐Reza Khosravi, Samaneh Mostafavi, Sanaz Bastan, Narges Ebrahimi, Roya Safari Gharibvand, Nahid Eskandari. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Communications 2024; 44(5): 521 doi: 10.1002/cac2.12539
|